Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 1005-1012

  Yamada, Masateru ^a   Niki, Hisae ^a   Yamashita, Masamichi ^a   Mue, Suetsugu ^b   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SENDAI NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; DEXAMETHASONE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PIROXICAM; PROSTAGLANDIN E2; TENOXICAM; AURANOFIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOBLOTTING; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RAT; RHEUMATOID ARTHRITIS; TREATMENT PLANNING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; MALE; METABOLISM; PERITONEUM MACROPHAGE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AURANOFIN; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ISOENZYMES; MACROPHAGES, PERITONEAL; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030610434     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. ALI, H., CHRISTENSEN, S. B., FOREMAN, J. C., PIOTROSKI, W. AND THASTRUP, O.: The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br. J. Pharmacol. 85: 705-712, 1985.
2. APPLETON, I., TOMILSON, A., MITCHEL, J. A. AND WILLOUGHBY, D. A.: Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti-inflammatory therapy. J. Pathol. 176: 413-420, 1995.
3. BARNETT, J., CHOW, J., IVES, D., CHIOU, M., MACKENZIE, R., OSEN, E., NGUYEN, B., TSING, S., BACH, C., FREIRE, J., CHAN, H., SIGAL, E. AND RAMESHA, C.: Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim. Biophys. Acta 1209: 130-139, 1994.
4. BLACK, H. E.: Renal toxicity of non-steroidal anti-inflammatory drugs. Toxicol. Pathol. 14: 83-90, 1986.
5. BONDESON, J. AND SUNDLER, R.: Auranofin inhibits the induction of interleukin 1β and tumor necrosis factor α mRNA in macrophages. Biochem. Pharmacol. 50: 1753-1759, 1995.
6. BROOKS, P. M. AND DAY, R. O.: Nonsteroidal antiinflammatory drugs-differences and similarities. N. Engl. J. Med. 324: 1716-1725, 1991.
7. CARSON J. L., STROM, B. L., SOPER, K. A., WEST, S. L. AND MORSE, M. L.: The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch. Intern. Med. 147: 85-88, 1987.
8. CLIVE, D. M. AND STOFF, J. S.: Renal syndromes associated with nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 310: 563-572, 1984.
9. COPELAND, R. A., WILLIAMS, J. M., GIANNARAS, J., NURENBERG, S., COVINGTON, M., PINTO, D., PICK, S. AND TRZASKOS, J. M.: Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc. Natl. Acad. Sci. U.S.A. 91: 11202-11206, 1994.
10. CROMLISH, W. A., PAYETTE, P., CULP, S. A., OUELLET, M., PERCIVAL, M. D. AND KENNEDY, B. P.: High-level expression of active cyclooxygenase-2 in insect cells. Arch. Biochem. Biophys. 314: 193-199, 1994.
11. DAVIS, P., JOHNSTON, C., MILLER, C. L. AND WONG, K.: Effects of gold compounds on the function of phagocytic cells. II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes. Arthritis Rheum. 26: 82-86, 1983.
12. DEWITT, D. L. AND SMITH, W. L.: Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. U.S.A. 85: 1412-1416, 1988.
13. DEWTT, D. L. AND SMITH, W. L.: Cloning of sheep and mouse prostaglandin endoperoxide synthases. Meth. Enzymol. 187: 469-479, 1990.
14. DIMARTINO, M. J. AND WALTZ, D. T.: Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent. Inflammation 2: 131-142, 1977.
15. DUBOIS, R. N., AWAD, J., MORROW, J., ROBERTS, L. J., II AND BISHOP, P. R.: Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest. 93: 493-498, 1994.
16. ENGELHARDT, G., BOGEL, R., SCHNITZER, C. AND UTZMANN, R.: Meloxicam: Influence on arachidonic acid metabolism. Part 1. In vitro findings. Biochem. Pharmacol. 51: 21-28, 1996a.
17. ENGELHARDT, G., BOGEL, R., SCHNITZLER, C. AND UTZMANN, R.: Meloxicam: Influence of arachidonic acid metabolism. Part II. In vivo findings. Biochem. Pharmacol. 51: 29-38, 1996b.
18. EVETT, G. E., XIE, W., CHIPMAN, J. G., ROBERTSON, D. L. AND SIMMONS, D. L.: Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: Regulation by dexamethasone, mitogens, and oncogenes. Arch. Biochem. Biophys. 306: 169-177, 1993.
19. FINKELSTEIN, A. E., ROISMAN, F. R. AND WALTZ, D. T.: Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes. Inflammation 2: 143-150, 1977.
20. FLETCHER, B. S., KUBUJU, D. A., PERRIN, D. M. AND HERSCHMAN, H. R.: Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267: 4338-4344, 1992.
21. FUNK, C. D., FUNK, L. B., KENNEDY, M. E., PONG, A. S. AND FITZGERALD, G. A.: Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 5: 2304-2312, 1991.
22. FUTAKI, N., TAKAHASHI, S., YOKOYAMA, M., ARAI, I., HIGUCHI, S. AND OTOMO, S.: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55-59, 1994.
23. HAFSTROM, I., UDEN, A. M. AND PALMBLAD, J.: Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients. Scand. J. Rheumatol. 12: 97-105, 1983.
24. HLA, T. AND NEILSON, K.: Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. U.S.A. 89: 7384-7388, 1992.
25. HSI, L. C., HOGANSON, C. W., BABCOCK, G. T. AND SMITH, W. L.: Characterization of a tyrosyl radical in prostaglandin endoperoxide synthase-2. Biochem. Biophys. Res. Commun. 202: 1592-1598, 1994.
26. KUBUJU, D. A., FLETCHER, B. S., VARNUM, B. C., LIM, R. W. AND HERSCHMAN, H. R.: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266: 12866-12872, 1991.
27. KUBUJU, D. A. AND HERSCHMAN, H. R.: Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem. 267: 7991-7994, 1992.
28. LEE, S. H., SOYOOLA, E., CHANMUGAM, P., HART, S., SUN, W., ZHONG, H., LIOU, S., SIMMONS, D. AND HWANG, D.: Selective expression of a mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267: 25934-25938, 1992.
29. LEVI, S. AND SHAW-SMITH, C.: Non-steroidal anti-inflammatory drugs: How do they damage the gut? Br. J. Rheumatol. 33: 605-612, 1994.
30. LEWIS, A. J., CARLSON, R. P., CHANG, J. AND DELUSTRO, F.: Effect of gold salts, D-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats. Agents Actions 14: 707-714, 1984.
31. MANCINI, J. A., RIENDEAU, D., FALGUEYRET, J. P., VICKERS, P. J. AND O'NEILL, G. P.: Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety. J. Biol. Chem. 270: 29372-29377, 1995.
32. MASFERRER, J. L., SEIBERT, K., ZWEIFEL, B. AND NEEDLEMAN, P.: Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A. 89: 3917-3921, 1992.
33. MASFERRER, J. L., ZWEIFEL, B. S., MANNING;, P. T., HAUSER, S. D., LEAHY, K. M., SMITH, W. G., ISAKSON, P. C. AND SEIBERT, K.: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91: 3228-3232, 1994.
34. MEADE, E. A., SMITH, W. L. AND DEWITT, D. L.: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268: 6610-6614, 1993.
35. MERLIE, J. P., FAGAN, D., MUDD, J. AND NEEDLEMAN, P.: Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J. Biol. Chem. 263: 3550-3553, 1988.
36. MITCHELL, J. A., BELVISI, M. G., AKARASEREENONT, P., ROBBINS, R. A., KWON, O. J., CROXTALL, J., BARNES, P. J. AND VANE, J. R.: Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation by dexamethasone. Br. J. Pharmacol. 113: 1008-1014, 1994.
37. MOSMANN, T.: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55-63, 1983.
38. NIKI, H., TOMINAGA, Y., WATANABE-KOBAYASHI, M., MUE, S. AND OHUCHI, K.: Possible participation of cyclooxygenase-2 in the recurrence of allergic inflammation in rats. Eur. J. Pharmacol., in press, 1997.
39. NISHIZUKA, Y.: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Wash. DC) 258: 607-614, 1992.
40. O'BANION, M. K., SADOWSKI, H. B., WINN, V. AND YOUNG, D. A.: A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol. Chem. 266: 23261-23267, 1991.
41. O'BANION, M. K., WINN, V. D. AND YOUNG, D. A.: cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 89: 4888-4892, 1992.
42. OHUCHI, K., SUGAWARA, M., WATANABE, M., HIRASAWA, N., TSURUFUJI, S., FUJIKI, H., CHRISTENSEN, S. B. AND SUGIMURA, T.: Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages. Br. J. Pharmacol. 94: 917-923, 1988.
43. 2 production by 12-0-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide. Biochim. Biophys. Acta 834: 42-47, 1985.
44. O'NEIL, G. P. AND FORD-HUTCHINSON, A. W.: Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330: 156-160, 1993.
45. O'NEIL, G. P., MANCINI, J. A., KARGMAN, S., YERGEY, J., KWAN, M. Y., FALGUEYRET, J. P., ABROMOVITZ, M., KENNEDY, B. P., OUELLET, M., CROMLISH, W., CULP, S., EVANS, J. F., FORD-HUTCHINSON, A. W. AND VICKERS, P. J.: Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: Inhibition by nonsteroidal antiinflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol. Pharmacol. 45: 245-254, 1994.
46. O'SULLIVAN, M. G., CHILTON, F. H., HUGGINS, E. M., JR. AND MCCALL, C. E.: Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J. Biol. Chem. 267: 14547-14550, 1992a.
47. O'SULLIVAN, M. G., HUGGINS, E. M., JR., MEADE, E. A., DEWITT, D. L. AND MCCALL, C. E.: Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem. Biophys. Res. Commun. 187: 1123-1127, 1992b.
48. PETERS-GOLDEN, M. AND SHELLY, C.: The oral gold compound auranofin triggers arachidonate release and cyclooxygenase metabolism in the alveolar macrophage. Prostaglandins 36: 773-786, 1989.
49. 2+-ATPase inhibitor thapsigargin. J. Biol. Chem. 263: 24751-24757, 1993.
50. ROME, L. H., LANDS, W. E., ROTH, G. J. AND MAJERUS, P. W.: Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandins. Prostaglandins 11: 23-30, 1976.
51. ROSEN, G. D., BIRKEMEIER, T. M., RAZ, A. AND HOLTZMAN, M. J.: Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem. Biophys. Res. Commun. 164: 1358-1365, 1989.
52. ROTH, G. J., MACHUGA, E. T. AND OZOLS, J.: Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthase. Biochemistry 22: 4672-4675, 1983.
53. RYSECK, R. P., RAYNOSCHECK, C., MACDONALD-BRAVO, H., DORFMAN, K., MATTEI, M. G. AND BRAVO, R.: Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ. 3: 443-450, 1992.
54. SANO, H., HLA, T., MAIER, J. A., CROFFORD, L. J., CASE, J. P., MACIAG, T. AND WILDER, R. L.: In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest. 89: 97-108, 1992.
55. SCHEINBERG, M. A., SANTOS, L. M. AND FINKELSTEIN, A. E.: The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes. J. Rheumatol. 9: 366-369, 1982.
56. SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. AND ISAKSON, P.: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91: 12013-12017, 1994.
57. SIMMONS, D. L., XIE, W., CHIPMAN, J. G. AND EVETT, G. E.: Multiple cyclooxygenase: Cloning of a mitogen inducible form. In Prostaglandins. Leukotrienes, Lipoxins, and PAF, ed. by J. M. Bailey, pp. 67-78, Plenum Press, New York, 1991.
58. SIMON, L.: Actions and toxic effects of the nonsteroidal anti-inflammatory drugs. Curr. Opin. Rheumatol. 6: 238-251, 1994.
59. SMITH, W. L., MEADE, E. A. AND DEWITT, D. L.: Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann. N.Y. Acad. Sci. 744: 50-57, 1994.
60. TADA, H., SHIHO, H., KUROSHIMA, K., KOYAMA, M. AND TSUKAMOTO, K.: An improved colorimetric assay for interleukin 2. J. Immunol. Meth. 93: 157-165, 1986.
61. TANIGUCHI, Y., IKESUE, A., YOKOYAMA, K., NODA, K., DEBUCHI, H., NAKAMURA, T., TODA, A. AND SHIMENO, K.: Selective inhibition by nimesulide, a novel nonsteroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharm. Sci. 1: 173-175, 1995.
62. THASTRUP, O., FODER, B. AND SCHARFF, O.: The calcium mobilizing, tumor promoting agent thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotion. Biochem. Biophys. Res. Commun. 142: 654-660, 1987.
63. WANG, C. AND SMITH, R. L.: Lowry determination of protein in the presence of Triton X-100. Anal. Biochem. 63: 414-417, 1975.
64. WARD, J. R., WILLIAMS, H. J., BOYCE, E., EGGER, M. J., READING, J. C. AND SAMUELSON, C. O., JR.: Comparison of auranofin. gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses. Am. J. Med. 75: 133-137, 1983.
65. WATANABE, M., YAMADA, M., MUE, S. AND OHUCHI, K.: Enhancement by cyclooxygenase inhibitors of platelet-activating factor production in thapsigarginstimulated macrophages. Br. J. Pharmacol. 115: 2141-2147, 1995.
66. WENGER, M. E., ALEXANDER, S., BLAND, J. H. AND BLECHMAN, W. J.: Auranofin versus placebo in the treatment of rheumatoid arthritis. Am. J. Med. 75: 123-127, 1983.
67. XIE, W., CHIPMAN, J. G., ROBERTSON, D. L., ERIKSON, R. L. AND SIMMONS, D. L: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 88: 2693-2696, 1991.